Staff

Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 NASH Data and Multiple Oral Abstracts at EASL’s International Liver Congress™

Staff June 25, 2022

Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program

Staff June 25, 2022

Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update

Staff June 25, 2022

Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™

Staff June 25, 2022

Jushi Holdings Inc. Amends and Refiles Q1 2022 Financial Statements

Staff June 25, 2022

Aleafia Health to Announce Fiscal Year 2022 Fifth Quarter and Year End Results – Update

Staff June 25, 2022

Aleafia Health Inc. Announces Closing of $5.6M Private Placement

Staff June 25, 2022

Century Therapeutics Announces Its Addition to the Russell Microcap® Index

Staff June 25, 2022

Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Staff June 25, 2022

Hepion Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders

Staff June 25, 2022

Report – ERYTECH’s Combined Shareholders’ Meeting On June 24, 2022

Staff June 25, 2022

Clover Health Set to Join Russell 3000® Index

Staff June 25, 2022

SeqLL Inc. Receives Nasdaq Notification Regarding Minimum Bid Requirements

Staff June 25, 2022

Cronos Group Inc. Announces Results of 2022 Annual Meeting of Shareholders

Staff June 25, 2022

Sorrento Therapeutics, Inc. announces the appointment of the Honorable Tommy G. Thompson, as Covid-19 Special Consultant to Chairman and CEO Henry Ji

Staff June 25, 2022

NFL BIOSCIENCES TO PRESENT AT THE H.C.WAINWRIGHT 1ST ANNUAL MENTAL HEALTH CONFERENCE

Staff June 25, 2022

Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001

Staff June 25, 2022

New development dynamics and confirmed business strategy

Staff June 25, 2022

Better For You Wellness Announces Replacement of Independent Director

Staff June 24, 2022

Columbus, Ohio--(Newsfile Corp. - June 24, 2022) - Better For You Wellness, Inc. (OTCQB: BFYW) ("Better For You Wellness" or...

Rushnet, Inc Current Status Update on the Progress Towards heliosDX Spinout and Capital Raise Through Tier 2 Regulation A

Staff June 24, 2022

ALPHARETTA, GA / ACCESSWIRE / June 24, 2022 / RushNet, Inc (OTC PINK:RSHN), (the "Company") is pleased to provide this...

Staff

Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 NASH Data and Multiple Oral Abstracts at EASL’s International Liver Congress™

Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program

Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update

Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™

Jushi Holdings Inc. Amends and Refiles Q1 2022 Financial Statements

Aleafia Health to Announce Fiscal Year 2022 Fifth Quarter and Year End Results – Update

Aleafia Health Inc. Announces Closing of $5.6M Private Placement

Century Therapeutics Announces Its Addition to the Russell Microcap® Index

Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Hepion Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders

Report – ERYTECH’s Combined Shareholders’ Meeting On June 24, 2022

Clover Health Set to Join Russell 3000® Index

SeqLL Inc. Receives Nasdaq Notification Regarding Minimum Bid Requirements

Cronos Group Inc. Announces Results of 2022 Annual Meeting of Shareholders

Sorrento Therapeutics, Inc. announces the appointment of the Honorable Tommy G. Thompson, as Covid-19 Special Consultant to Chairman and CEO Henry Ji

NFL BIOSCIENCES TO PRESENT AT THE H.C.WAINWRIGHT 1ST ANNUAL MENTAL HEALTH CONFERENCE

Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001

New development dynamics and confirmed business strategy

Better For You Wellness Announces Replacement of Independent Director

Rushnet, Inc Current Status Update on the Progress Towards heliosDX Spinout and Capital Raise Through Tier 2 Regulation A

MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics

MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics

MindHYVE.ai™ and KPSIAJ Sign Strategic MOU to Advance AI-Driven Innovation in Education and Healthcare Across Karachi

Castle Connolly Names Dr. Meegan Gruber, MD, PhD a 2026 Exceptional Woman in Medicine; Recognition to Be Featured in New York Magazine

Planning Time Off in 2026: Dr. Meegan Gruber, MD, PhD Releases a Recovery-Logistics Guide for Busy Professionals Considering Plastic Surgery

You may have missed